Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.71 B1.73 B1.79 B1.94 B1.92 B 7.38 B Research & development ————— — Operating income 680 M1.17 B744 M952 M808 M 3.68 B Non-Operating Income, Total -1.33 B-166 M108 M21 M115 M 78 M Interest expense, net of interest capitalized 137 M151 M157 M154 M148 M 610 M Non-Operating Income, excl. Interest Expenses -1.45 B-415 M-184 M-133 M-117 M -849 M Unusual income/expense -16 M98 M135 M—84 M — Pretax income 561 M874 M714 M930 M795 M 3.31 B Equity in earnings 16 M19 M19 M11 M20 M 69 M Taxes 154 M230 M137 M261 M228 M 856 M Non-controlling/minority interest 5 M3 M3 M4 M4 M 14 M After tax other income/expense -56 M-49 M-4 M-28 M36 M -45 M Net income before discontinued operations 402 M641 M743 M665 M560 M 2.61 B Discontinued operations ————— — Net income 402 M641 M743 M665 M560 M 2.61 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 402 M641 M743 M665 M560 M 2.61 B Basic earnings per share (Basic EPS) 0.310.490.570.520.44 2.02 Diluted earnings per share (Diluted EPS) 0.310.490.570.520.44 2.02 Average basic shares outstanding 1.3 B1.29 B1.29 B1.29 B1.28 B — Diluted shares outstanding 1.3 B1.3 B1.3 B1.3 B1.29 B — EBITDA 2.34 B2.85 B2.48 B2.93 B2.66 B 10.91 B EBIT 1.44 B2.6 B2.23 B2.56 B2.41 B 9.8 B Cost of revenue 6.88 B6.05 B7.13 B7.54 B7.28 B 28 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 237 M250 M250 M365 M250 M 1.11 B